Intralipid

Soya Oil, the active ingredient in Intralipid, is a intravenous lipid emulsion presented as a sterile emulsion for intravenous use. It provides calories and essential fatty acids for patients receiving parenteral nutrition, including those who cannot tolerate enteral feeding. GNH USA supplies Intralipid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Intralipid is used in the management of nutritional support and essential fatty acid deficiency in patients requiring parenteral feeding. - Parenteral nutrition in patients unable to receive enteral feeding: supplies calories and essential fatty acids to maintain energy balance. - Prevention of essential fatty acid deficiency: delivers linoleic and linolenic acids needed for cell membrane integrity. - Critical care caloric support: provides an immediate source of energy for critically ill patients on total parenteral nutrition.

Intralipid may be associated with a range of adverse reactions.

Common Side Effects: - Hypertriglyceridemia: elevated serum triglyceride levels during therapy. - Fever or chills: transient temperature rise after infusion. - Nausea or vomiting: gastrointestinal discomfort. - Headache: mild to moderate intensity. - Injection site reactions: erythema or discomfort.

Serious or Rare Side Effects: - Fat overload syndrome: severe metabolic disturbance from excessive lipid load. - Pancreatitis: inflammation of the pancreas related to high triglyceride levels. - Anaphylaxis or severe allergic reaction: rapid onset respiratory or cardiovascular compromise. - Pulmonary embolism: rare embolic events from lipid particles. - Hepatic dysfunction: abnormal liver enzymes or steatosis.

Prior to initiating Intralipid therapy, clinicians should consider several safety measures. - Monitor triglyceride levels: check serum triglycerides regularly to avoid hyperlipidemia. - Assess infection risk: avoid use in patients with uncontrolled sepsis. - Evaluate liver function: monitor hepatic enzymes during prolonged therapy. - Check for soy or egg phospholipid allergy: contraindicated in known hypersensitivity. - Use caution in pancreatitis history: consider alternative nutrition strategies. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intralipid can interact with other medications and nutritional products, requiring careful management.

Major Interactions (Avoid): - Concurrent propofol infusion: combined lipid load may cause fat overload. - Co‑administration with other lipid‑containing parenterals: risk of cumulative hypertriglyceridemia. - Use with fibrates: may exacerbate triglyceride elevation.

Moderate Interactions (Monitor Closely): - Heparin therapy: may alter triglyceride metabolism. - Corticosteroids: can increase serum triglyceride concentrations. - Dextrose‑containing total parenteral nutrition: monitor glucose and lipid balance.